| Analysis | Metabolite Name | Measured Value | Units | Group | Timepoint | Gender | Age at start of study (years) |
|---|---|---|---|---|---|---|---|
| GC POSITIVE ION MODE | pyruvic acid | 1048 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | pyruvic acid | 1305 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | pyruvic acid | 1310 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | pyruvic acid | 1654 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | pyruvic acid | 1904 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | pyruvic acid | 2086 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | pyruvic acid | 2106 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 7 |
| GC POSITIVE ION MODE | pyruvic acid | 2289 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | pyruvic acid | 2350 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | pyruvic acid | 2628 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | pyruvic acid | 2651 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | pyruvic acid | 2765 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | pyruvic acid | 2808 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | pyruvic acid | 3028 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | pyruvic acid | 3172 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | pyruvic acid | 3223 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 9 |
| GC POSITIVE ION MODE | pyruvic acid | 3808 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | pyruvic acid | 3888 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | pyruvic acid | 4773 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | pyruvic acid | 4967 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | pyruvic acid | 5189 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | pyruvic acid | 5262 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | pyruvic acid | 5509 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | pyruvic acid | 5797 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | pyruvic acid | 5855 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 10 |
| GC POSITIVE ION MODE | pyruvic acid | 6532 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | pyruvic acid | 6751 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 9 |
| GC POSITIVE ION MODE | pyruvic acid | 7093 | Counts | Synbiotic | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | pyruvic acid | 7742 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | pyruvic acid | 7837 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | pyruvic acid | 8057 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | pyruvic acid | 8129 | Counts | Synbiotic | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | pyruvic acid | 8360 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | pyruvic acid | 8570 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | pyruvic acid | 8720 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | pyruvic acid | 8957 | Counts | Synbiotic | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | pyruvic acid | 9977 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | pyruvic acid | 10505 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 5 |
| GC POSITIVE ION MODE | pyruvic acid | 10857 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | pyruvic acid | 11084 | Counts | Synbiotic | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | pyruvic acid | 11164 | Counts | Placebo | Baseline (days 5-7) | Male castrated | 7 |
| GC POSITIVE ION MODE | pyruvic acid | 11434 | Counts | Placebo | Recovery (days 68-70) | Female spayed | 10 |
| GC POSITIVE ION MODE | pyruvic acid | 11482 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 5 |
| GC POSITIVE ION MODE | pyruvic acid | 15629 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | pyruvic acid | 17083 | Counts | Placebo | Recovery (days 68-70) | Male castrated | 7 |
| GC POSITIVE ION MODE | pyruvic acid | 18814 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | pyruvic acid | 19785 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 7 |
| GC POSITIVE ION MODE | pyruvic acid | 22007 | Counts | Placebo | Completion of treatment (days 26-28) | Female spayed | 5 |
| GC POSITIVE ION MODE | pyruvic acid | 23441 | Counts | Synbiotic | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | pyruvic acid | 23815 | Counts | Placebo | Baseline (days 5-7) | Female spayed | 7 |
| GC POSITIVE ION MODE | pyruvic acid | 28235 | Counts | Placebo | Completion of treatment (days 26-28) | Male castrated | 9 |
| GC POSITIVE ION MODE | pyruvic acid | 28613 | Counts | NA | NA | NA | - |
| GC POSITIVE ION MODE | pyruvic acid | 30014 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 5 |
| GC POSITIVE ION MODE | pyruvic acid | 32689 | Counts | Synbiotic | Completion of treatment (days 26-28) | Female spayed | 10 |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|